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Abstract
Background: High-flow nasal cannula (HFNC) is a type of non-invasive respiratory support that
has decreased the rate of intubation in infants and children. It is utilized in the PICU and the
wards. Due to the increased volume of patients on HFNC, a standard HFNC weaning protocol
was created to improve the management of these patients.
Methods: Potential patients were identified through the Virtual Pediatric System (VPS) with the
criteria of ages 1 month to 6 years old, admitted to the PICU during the months of January to
March of 2018 and 2019, with diagnosis of bronchiolitis and requiring HFNC. Chart review was
then conducted to eliminate the patients that did not meet the inclusion criteria. There were 48
patients in the pre-protocol group and 70 patients in the post protocol group. Further chart review
was conducted to gather the information on the 2 groups.
Results: Using independent t-test comparing the pre- and post-weaning protocol groups showed
no significant differences between the pre- and post-protocol groups in PICU length of stay
(2.3±1.8 vs 2.1±2.1d), hospital length of stay (4.8±2.2 vs 4.2±1.6d ), and duration of HFNC use
(87.4±47 vs 74.2±37.4 hr). The magnitude of difference in the means of the hospital length of
stay and PICU length of stay were small (eta squared=0.02; 0.002 respectively).

Key words: Bronchiolitis; weaning; protocol; HFNC; RSV; infants; children; pediatric; hospital
length of stay; PICU length of stay
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The Effect of High Flow Nasal Cannula Weaning Protocol on Decreasing Length of Stay in
Pediatric Intensive Care
Bronchiolitis in infants and young children is one of the most common reasons for
admission to the hospital as it causes lower respiratory infections (McKiernan, Chua, Visintainer,
& Allen, 2010). Symptoms of bronchiolitis include increased work of breathing, cough,
rhinorrhea, tachypnea, tachycardia, fever, wheeze, and hypoxia related to bronchiole obstruction
due to mucus plugging and edema (McKiernan et al., 2010). The management of bronchiolitis
involves solely supportive care which can include respiratory support, IV hydration, and comfort
measures (Hanlon, 2014).
High-flow nasal cannula (HFNC) is a method of non-invasive respiratory support that
delivers heated high flow via nasal cannula providing continuous positive airway pressure and
having the option to increase or decrease oxygen concentration (McKiernan et al., 2010). HFNC
tends to be well-tolerated in infants and children, decreasing the need for sedation, and most
likely decreasing the rate for invasive mechanical ventilation (McKiernan et al., 2010).
At Norton Children’s Hospital, weaning of HFNC liter flow was dependent on the
decision of healthcare providers (physician, resident, and/or nurse practitioner) caring for the
patient which could be delayed due to unexpected interruptions. A multidisciplinary team created
a weaning protocol for the patients on the wards and this was extended to the PICU. With the use
of a weaning protocol by both the PICU and wards, the hope that this will lead to fewer PICU
and hospital days. With the use of the HFNC protocol, one would hypothesize a decrease in the
time on HFNC.
A literature review was conducted determine if there are any standard use protocols for
HFNC for infants and children in the Pediatric Intensive Care and Medical-Surgical floors.
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The literature review was performed using CINAHL, Cochrane, National Guidelines
Clearinghouse and MEDLINE with the following keywords: high-flow nasal cannula,
bronchiolitis, weaning, pediatric intensive care, infants, and children. Limitations in this review
include literature published from 2010-2017, in English, children ages 0-18, and hospital-based
studies. Fifteen articles were reviewed and of those 15 articles, seven were retrospective
studies, five prospective studies, and three literature reviews (See Appendix A). The seven
retrospective studies include two that evaluated the efficacy of the HFNC by comparing preHFNC and post-HFNC in the PICU (Kawaguchi, Yasui, deCaen, & Garros, 2017; McKiernan et al.,
2010) and one study compared the use of CPAP verses the use of HFNC (Metge et al., 2014).
Two of the studies compared the use of HFNC in the PICU and in the wards (Goh, Kirby, Schell,
& Egan, 2017; Riese, Fierce, Riese, & Alverson, 2015) and two evaluated the use of HFNC in the
PICU (Coletti, Bagdure, Walker, Remy, & Custer, 2017; Wraight & Ganu, 2015). Of the five
prospective studies, one study created and evaluated a “holiday” based weaning protocol
(Betters et al., 2017), two evaluated the effect of different flow rates on the effect of breathing
(Hough, Pham, & Schibler, 2014; Weiler et al., 2017), and two evaluated the efficiency of
oxygen therapy via HFNC (Bressan et al., 2013; Oto, Erdoğan, & Boşnak, 2016). Two of the three
articles that were reviewed examined the mechanisms of action, effectiveness, safety,
tolerance, and complications of HFNC with the reviews providing evidence of the safety,
efficacy, and well-tolerated HFNC (Hutchings, Hilliard, & Davis, 2015; Mikalsen, Davis, & Øymar,
2016), while the third literature review searched for protocols to wean or discontinue HFNC in
preterm infants with the conclusion there is an absence of protocols and further studies are
needed to provide evidence for practice (Farley, Hough, & Jardine, 2015).
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With the wide use of HFNC in the PICU, the use of HFNC has expanded to the pediatric
wards at some institutions as a means of respiratory support. Several retrospective studies
examined the use of HFNC in the PICU before and after introduction to the pediatric wards (Goh
et al., 2017; Riese et al., 2015). Although starting HFNC on the pediatric wards did not decrease
the rate of PICU admission, the use of HFNC did lead to a decrease in need for intubation and
length of hospital stay (Goh et al., 2017; Riese et al., 2015). Another prospective observational
study examined the introduction of HFNC on the pediatric wards and evaluated patients less than
12 months old admitted for moderate to severe bronchiolitis (Bressan et al., 2013). Twenty-seven
patients were enrolled and placed on HFNC; all patients saw an improvement in respiratory rate
and ETCO2; none of the twenty-seven patients required PICU admission (Bressan et al., 2013).
The literature review search resulted in a single study evaluating a weaning protocol and
a 2015 Cochrane review for weaning protocols for pre-term infants. This Cochrane review was
conducted examining available literature regarding weaning strategies for infants on HFNC
(Farley et al., 2015). The review included randomized control studies, quasi-RCT, and any
weaning protocols searching up to the year 2015, but was unable to find any studies meeting the
inclusion criteria (Farley et al., 2015). The authors stated the need for specific criteria to define
what parameters would constitute the time to wean HFNC and what defines failure to wean
HFNC (Farley et al., 2015).
Since the Cochrane review was completed in 2015, one single center study created a
“holiday” protocol for the PICU using a Respiratory Assessment Score (RAS) to evaluate the
readiness of the patient for weaning from HFNC (Betters et al., 2017). The HFNC holiday
protocol is based on the RAS scores which will determine if the patient remains on the same
flow rate, decrease flow rate by half, or transition to conventional nasal cannula. Of the 133
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patients in the study, 119 patients were successfully weaned off HFNC to low flow nasal cannula
with 83 patients weaned in the first attempt, 26 patients with the second attempt, nine patients
with the third attempt, and one patient weaned in four attempts (Betters et al., 2017). None of the
36 patients who were weaned after several attempts require escalation of respiratory support. The
RAS was created from a combination of the Wood-Downes score and Silverman-Andersen
Respiratory Distress Index with scores ranging from 0-2 in six categories with a potential total
score of 12 points. Respiratory therapists (RTs) screened the patients twice a day with the use of
RAS to determine if the patient qualified for a “holiday” off HFNC. Scores of six or less
qualified for a “holiday,” scores of 7-8 prompted a decrease in the flow rate by half, and scores
greater than eight had no direct change. They also examined the PICU LOS (5 vs 21 days;
p<0.0001) and total hospital LOS (9 vs 28.5 days; p<0.001) and both LOS were lower in the
successful weaning group as compared to the unsuccessful weaning group (Betters et al., 2017).
This study was the first to examine a protocol for weaning HFNC and showed it was efficient,
timely, and safe.
Hutchings, Hilliard, and Davis (2015) discussed the development of guidelines of HFNC
management in their institution and the use of the Pediatric Early Warning (PEW) Score as an
indication to escalate or wean the HFNC. An algorithm was created to develop guidelines in the
management of HFNC and the timing of transferring a patient to the PICU (Hutchings et al.,
2015). Initial FIO2 was set at 40 % and the flow was set dependent on age. However, the authors
did not discuss the timing, success or failure of the guidelines.
Theoretical Framework
Donabedian’s health care quality model is a framework designed to evaluate the quality
of health care (See Appendix D). The Donabedian’s model has three categories which include
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structure, process, and outcome (Donabedian, 1988). The structure is the setting in which health
care is provided. This may include a facility, equipment, providers, and patients. The process is
the operations between patients and providers that occur throughout the healthcare delivery. The
process ranges from diagnosis to preventive intervention to treatment. The outcome is the effects
of healthcare on patients’ health. This model is perfect for the quality improvement study of
evaluating the HFNC weaning protocol.
Setting and Organizational Assessment
Data were reviewed during 3-month periods of January to March 2018 (pre-protocol) and
January to March 2019 (post protocol) at Norton Children’s Hospital PICU. The Children’s
Hospital has a 300-bed capacity with PICU having 36-bed unit serving the tri-state area
(Kentucky, Indiana, and Ohio).
Purpose
The use of HFNC is increasing in the hospital setting, including the wards, ED, and
PICU. With the increased use of HFNC, the implementation of a standard weaning protocol that
can be used for infant and children in any inpatient hospital setting could potentially improve
multiple child outcomes. The hypothesis is that the use of a standardized HFNC protocol would
decrease the length of stay in the PICU, hospital length of stay, and length of time on HFNC.
With the decrease in length of stay, this would lead to improved child outcomes and decreased
healthcare costs to the family.
This study compared data from infants and children three months (January-March 2018)
prior to the initiation of the HFNC weaning protocol with infants and children during the same
three months (January-March 2019) post-initiation of the protocol examining the LOS in PICU,
hospital LOS, adverse events, and length of HFNC use. During the winter and spring months,
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our institution has the highest frequency of admissions for bronchiolitis. The Children’s Hospital
wards have implemented a weaning protocol that is accessible in EPIC, which is our electronic
medical record system (see Appendix C). This protocol was used in the PICU and continued
with the transfer of the patient to the wards.
Intervention
The HFNC weaning protocol was implemented in the PICU in January-March 2019. The
HFNC weaning protocol order set is present in EPIC (See Appendix C). The weaning protocol
was initiated when the patient required oxygen of 40% or less, with saturations greater than 90
%, and respiratory rate less than 60 breaths per minute for infants one-month to one-year old,
less than 40 breaths per minute for one-to-two-year-old, and less than 30 breaths per minute for
three- to six-year-old children. The protocol was implemented by the RTs. Once the PICU
patient was on HFNC settings appropriate for the ward, the patient was transferred to the
pediatric wards and continued with the weaning protocol. The purpose of the project was to
examine the impact of standard HFNC weaning protocol on infants and children with
bronchiolitis ages one-month to six-years and shortening PICU LOS and hospital LOS, when
compared to those infants and children who did not receive the weaning protocol.
The quality improvement project was sent to the IRB for approval but was exempt. A
retrospective chart review was conducted to identify patients not placed on the HFNC weaning
protocol during the months of January to March 2018, for comparison with the data obtained
from patients placed on the HFNC weaning protocol during the months of January to March
2019.
Participants
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The participants were children admitted to the PICU at Norton Children’s Hospital
requiring HFNC support. The inclusion criteria were patients who were one-month to six-years,
diagnosed with bronchiolitis via clinical or viral confirmation, admitted to the PICU, and
requiring HFNC. The exclusion criteria were patients with diagnosis of status asthmaticus
requiring continuous albuterol, superimposed pneumonia demonstrated on chest x-ray, and an
additional history of chronic lung disease, neuromuscular disorders, and/or congenital heart
disease.
Data Collection
Virtual Pediatric System (VPS) which is a PICU comparative database used nationally
and internationally comparing the individual PICU data to other PICUs was used to search for
potential patients meeting the criteria. Data were collected using the Epic Electronic Medical
Record (EMR) system during the months of January to March 2018, for comparison with the
data obtained from patients placed on the HFNC weaning protocol during the months of January
to March 2019. Demographic characteristics, insurance, admission, transfer, and discharge dates,
and past medical history, were collected using EMR. The patients’ symptoms, vital signs,
laboratory tests, and medications were obtained along with length of time on HFNC, highest and
lowest HFNC settings, complications, and readmission to PICU within 24 hours of transfer.
Measurement
Multiple discussions were had with several PICU attendings to assess what information
would be beneficial to collect. The following data were deemed important to collect.
Demographic data collected included gender, ethnicity, insurance, age, and prematurity. Hospital
course data included admission, transfer, discharge dates, interval times on HFNC to time off
HFNC, and time weaning order placed. Vital signs collected included heart rate, respiratory rate,
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and saturations at initiation of HFNC and at one-hour post HFNC initiation. Additional tests
assessed included chest x-ray, blood, urine, and spinal fluid cultures, and respiratory panel.
Additional therapies utilized included antibiotics, breathing treatments, steroids, and fluids.
Complications of significance included escalation of respiratory support or development of
pneumothorax (See Appendix B). The data that were missing pertained to vital signs and this
was addressed in the SPSS.
Results
SPSS 25 statistical software was used to analyzed the data. The sample included 48
patients (26 males; 54.1 %) in the pre-protocol group versus 70 (39 males; 55.7 %)) in the postprotocol group. Ages range from one month to 37 months (mean 7.6 mo and SD 7.57). Ethnicity
results were 70 % white, 20 % African American, and 17 % Hispanic. In regards to insurance, 39
% with private insurance and 59 % had government insurance (See Table 1). Twenty-four
percent were born premature (<37 weeks) with 15 patients in the pre-protocol and 13 patients in
the post-protocol groups. Forty-three percent of patients tested positive for RSV, 9% tested
positive for Rhino/Enterovirus, 21 % tested positive for multiple viruses, 14 % tested positive for
other viruses, 3 % tested negative, and 10 % were not tested (Table 5).
The independent t-test was used to compare the pre-post weaning protocol groups. The
results showed no significant differences between the pre- and post-protocol groups in PICU
length of stay (2.3±1.8 vs 2.1±2.1d; t(116)=0.52, p<0.603, two-tailed), hospital length of stay
(4.8±2.2 vs 4.2±1.6d; t(116)=1.66, p<0.098 two-tailed), and duration of HFNC use (87.4±47 vs
74.2±37.4 hr; t(116)=1.69, p<0.093 two-tailed). The magnitude of difference in the means of the
PICU length of stay (mean difference=0.15, 95 % CI: -0.42 to 0.71), hospital length of stay
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(mean=0.59, 95% CI: -0.11 to 1.29), and length of time on HFNC (mean difference= 13.19, 95%
CI: -2.25 to 28.64) were small (eta squared=0.02; 0.002; 0.02 respectively) (See Table 2).
Discussion
Interpretation
The results showed no significant difference of PICU length of stay and hospital
between the pre-post protocol groups (p<0.603 and p<0.098, respectively). The results
counteract what Betters et al. (2017) discovered when they implemented a HFNC weaning
protocol at their institution and reported a significant difference in PICU LOS between the group
(n=119) successful with the weaning protocol and the group (n=14) who failed the weaning
protocol (median 9 vs 21 d; p<0.001) and hospital LOS (median 9 vs 28.5; p<0.001). The
difference in results reflect the different parameters used as they compared the successful group
to the unsuccessful group whereas this author compared anyone placed on the protocol making
the comparisons between the two studies unequals. The protocol they created was in the form of
“holiday” as opposed to primarily weaning in specific time frame. The patients in the 2 groups
had a variety of diagnoses included asthma, bronchiolitis, trauma, pneumonia, and postoperative
which are difficult to compare due to the progression of the disease process. Those patients who
failed the weaning protocol were complicated postoperative patients including liver and bone
marrow transplants. Riese et al. (2015) saw a reduction in hospital LOS after initiation of HFNC
on the general pediatric wards (median 4 vs 3 d; p<0.001) and a decrease in HGNC length of
time from 2.4 days to 1.8 days. Goh et al (2017) also found a reduction in PICU LOS and
hospital LOS once HFNC was utilized on the general pediatric wards (median 2.2 d and 6 d
respectively). In the current study, there was no significant difference in HFNC length of time
between the pre-post protocol groups (p<0.093). The non-significant difference could be related
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to the small sample sizes and unequal groups with pre-protocol group of 48 patients and postprotocol group of 70 patients. Other factors that could have affected the results are the
compliance of following the protocol, the lack of timeliness in ordering the protocol, or lack of
ordering the protocol. These factors could be related to the fact that the protocol was new to the
PICU and with that there may be educational lacking with the RTs and healthcare providers.
The implementation of the HFNC weaning protocol remains an excellent way to utilize
the Respiratory Therapists’ (RT) skills and give them autonomy in respiratory care practice and
patient care. The HFNC weaning protocol gives professional ownership to RTs and takes the
sole responsibility from the healthcare providers who often have other distractions during the day
that may delay their ability to reassess the patients and wean HFNC as often as possible. Betters
et al., (2017) demonstrated that with the implementation of a HFNC weaning protocol it was
safe, timely, and efficient but also acknowledge the need for further studies with the use of
weaning protocol of larger population to determine the effectiveness of the weaning protocol on
PICU and hospital LOS.
As of now, at our hospital, the RTs are the only healthcare professionals to be able to
wean the flow rate. The bedside nurses are allowed to wean the oxygen. If the bedside nurses
were allowed to wean the flow, then the HFNC weaning protocol would be better utilized as both
nurses and RTs would assess the patient at different times which would promote consistency
with the weaning process. Betters et al., (2017) documented the use of RTs in using the weaning
protocol but made mentioned that the RTS were the only ones who were knowledgeable with the
scoring system created. With the potential for improved HFNC weaning procedures, then this
could lead to improved patient outcomes.
Limitations
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The limitations with this project include a small sample size which could lead to nonsignificant results and not represent the population well. The inconsistency of following the
HFNC weaning protocol by the RTs due to the busyness of the unit or delay in recognition of the
HFNC order placed could negatively influence patient outcomes. The timing of placing the
HFNC weaning protocol could be delayed due to multiple admissions or busyness of the unit.
The healthcare providers may not be aware of the HFNC weaning protocol.
Conclusion
The HFNC weaning protocol has great potential but consistency in physicians ordering
the protocol and RTs following the protocol remains potentially lacking. The results of the
project were insignificant but represented a small mean decrease in the post-protocol groups
concerning pediatric ICU and hospital length of stay and hours on HFNC. There needs to be a
change in the implementation of the HFNC weaning protocol such as including the weaning
protocol in place on admission to allow the RTs to use at their discretion. Also, it is important to
investigate if a bedside nursing practice change with nursing is feasible by contacting the Board
of Nursing and Norton Children’s Hospital. With the input of both nursing and RTs, the use of
HFNC weaning protocol would be maximized and more consistent implementation of the
protocol and following the protocol would occur to improve patient outcomes.
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Appendix A
Citation
Farley et al,
2015
Metge et al,
2014
Coletti et al,
2017
McKiernan et
al, 2010
Riese et al, 2015

Findings
No studies met the criteria for protocols weaning of HFNC in preterm
infants
No difference between using nCPAP (19 pt) and HFNC (15 pts)
Weaning: started when FiO2<25 %, PCO2<45 mmHg;
HFNC utilization on variety of dx (asthma, bronchiolitis, CHD)
Majority of pts <12 yrs; 10 % of pts (NIV) or intubation;
68 % decrease in need for intubation with the use of HFNC; pts on HFNC
had improvement within 1 hour of initiating HFNC
Decreased LOS with ward protocol; weaning HFNC faster on wards vs
PICU; 30 % of PICU pts transferred to floor on HFNC
Wraight et al,
42 pts (78%) on HFNC did not require intubation; 7 pts required CPAP; 5
2015
were intubated; 75% of patients failed within 8 hours
Goh et al, 2017
No difference in PICU admits from wards with HFNC on wards; Decrease
need for intubation and hospital LOS; Did not require higher than 2
L/kg/min
Kawaguchi et
HFNC group less likely to be intubated; shorter Mechanical ventilation
al, 2017
days; longer PICU LOS;
Betters et al,
119 of 133 pts weaned off HFNC (85%); median duration of 15 hrs; PICU
2017
LOS lower (5vs21, p<0.001)
Weiler et al,
Increase in flow rates decreased WOB, with most effective at 1.52017
2L/kg/min; and greater in pts <8kg
Oto et al, 2016
40 of the 50-pts improved on HFNC while 10 pts required intubated;
improvement seen on HFNC at 30 minutes/12 hrs;
Hough et al,
Increased in end-expiratory lung volume with higher HFNC of 8L/min;
2014
improved respiratory status; decreased FiO2 needs
Bressan et al,
HFNC used improved saturations, work of breathing; optimal option for pts
2013
with bronchiolitis; safe use on wards
Mikalsen et al,
HFNC safe, well-tolerated; increased PEEP, improve pulmonary
2016
compliance
Hutchings et al,
PEW scores used for escalation/weaning of HFNC, flow rate dependent on
2015
age, start at 40 % FiO2, algorithm for escalation
Abbreviations
HFNC-high flow nasal cannula; PICU-pediatric intensive care unit; pts-patients; EMR-electronic medical record;
dx-diagnosis; wt-weight; resp-respiratory; assess-assessment; hrs-hours; LOS-length of stay; RT-respiratory
therapist; HR-heart rate; RR-respiratory rate; WOB; work of breathing; nCPAP-nasal continuous positive airway
pressure; mos-months; yrs-years; NIV-non-invasive ventilation; MV-mechanical ventilation
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Appendix B
Data Collection Sheet
Age(months)

Treatment in ED

Treatment in PICU:

Sex

Albuterol

IVFs

Ethnicity

Steroids

Dietary

Insurance

ABX

Steroids

Weight(kg)

Fluid Hydration

Albuterol

Allergies
Admit last 30 days

Mucolytic
Prematurity (<37 weeks)

Antibiotics

Syndrome/Genetic
ED admit date

RAD/CLD

Complications-BiPAP

PICU admit date

FTT

Intubate

Transfer floor date
D/C home date
Bounce back within 24 hours
Initial HFNC
Heart Rate
Respiratory Rate

Pneumothorax
Labs: CXR
Respiratory Panel

Initial Time placed on HFNC

Blood culture

Time of order placed

Urine Culture

Time of 1st wean

Lumbar puncture

Time removed from HFNC

Saturations

Highest Flow

HFNC-Liters

# days of symptoms

Highest FiO2

HFNC-FiO2

Rhinorrhea

Lowest Flow

Fever

Lowest FiO2

1 hr. post HFNC initiation
Heart Rate
Respiratory Rate
Saturations

Cough

Respiratory support at time of
transfer to floor-HFNC; NC; RA

HFNC-Liters

Increased WOB

HFNC-FiO2

Congestion
Decreased PO intake
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Appendix C
HFNC Weaning Order Protocol
Patient less than 12 months of age







RT to evaluate every 4 hours
Wean HFNC every 4 hours
Wean by 1 LPM
Respiratory rate <60
Minimal retractions/accessary muscle use: no
retractions or only mild subcostal or
intercostal retractions
Goal 3 LPM and 25 % to transition to nasal
cannula

Patient 12 months or greater






RT to evaluate every 4 hours
Wean HFNC every 4 hours
Wean by 1-2 LPM
Respiratory rate <30-40
Minimal retractions/accessary muscle use: no retractions
or only mild subcostal or intercostal retractions



Goal 5 LPM and 25 % to transition to nasal cannula
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Appendix D
The Donabedian Model

Lighter, D. E. (2015). How (and why) do quality improvement professionals measure performance?. International
Journal of Pediatrics and Adolescent Medicine, 2(1), 7-11.
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Table 1
Demographics
Demographic Variables

N (%)

Gender- Male
Female

65 (55.1)
53 (44.9)

Ethnicity- White
African American
Hispanic
Other

83 (70.3)
23 (19.5)
8 (16.8)
4 (3.4)

Insurance- Private
Government
Unknown

46 (39)
70 (59.3)
2 (1.7)

N = 118

Table 2
Independent t-tests comparison of pre-post weaning groups
Variable Groups

Mean ± SD

t

dƒ

ƿ

PICU LOS
Pre-Protocol(n=48)

2.3±1.8d

0.52

116

0.603

1.66

116

0.098

1.69

116

0.093

Post-Protocol(n=70)

2.1±2.1d

Hospital LOS
Pre-Protocol(n=48)

4.8±2.2d

Post-Protocol(n=70)
HFNC Length of time
Pre-Protocol(n=48)
Post-Protocol(n=70)

4.2±1.6d

87.4±47hr
74.2±37.4hr
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Table 3
Age/weight
Age
Weight

1 month-37 months (M=7.4 mo; SD=2.7)
2.8-16.6 kg (M=7.4 kg; SD=2.7)

Table 4

Prematurity
Prematurity
No
Yes

N (%)
90 (76.3)
28 (23.7)

Table 5

Viruses
Viruses
RSV
Rhino/Enterovirus
Other
Multiple Viruses
Negative Test
No Test

N (%)
51 (43)
11 (9)
16 (14)
25 (21)
3 (3)
12 (10)

